A novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure
- PMID: 23399110
- DOI: 10.1016/j.mehy.2012.12.041
A novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure
Abstract
Acute renal failure (ARF) is a rapid loss of kidney function. The reasons and mechanism by which this occurs has not been clarified so far thus creating obstacles to management of this disease. Presently, the experimental research using the accepted renal ischemia reperfusion injury (I/R injury) model represented for ARF focuses on several possible relevant factors such as reactive oxygen species, no-reflow phenomenon, apoptosis and extensive inflammatory response. The latter is much talked about currently. Some intracellular danger sensing proteins, such as the nucleotide binding domain leucine rich repeats-containing family proteins known as NLRs, adjust the inflammatory response through the formation of a multi-protein complex known as an inflammasome. The most classic family member of this complex is NALP3 confirmed to serve as a contributor to I/R injury. However, how it contributes to the pathology remains obscure. The extensive inflammatory response is considered to be modulated by the mitogen-activated protein kinases (MAPK) signaling pathway. NOD2, another family member of NLR, which shares similar structure with NALP3, indicated that it induced the activation of MAPK in response to a pathogen, thus we assumed that NALP3 performed the harmful process of I/R injury, resulting probably from the activation of the MAPK signaling pathway. If this hypothesis proves to be correct, it might benefit the management of ARF.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice.Hum Gene Ther. 2011 Jul;22(7):853-64. doi: 10.1089/hum.2010.145. Epub 2011 Mar 7. Hum Gene Ther. 2011. PMID: 21128730
-
Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion.FEBS J. 2015 Jan;282(2):259-70. doi: 10.1111/febs.13123. Epub 2014 Nov 14. FEBS J. 2015. PMID: 25327779
-
NLRP3 regulates neutrophil functions and contributes to hepatic ischemia-reperfusion injury independently of inflammasomes.J Immunol. 2014 May 1;192(9):4342-51. doi: 10.4049/jimmunol.1302039. Epub 2014 Apr 2. J Immunol. 2014. PMID: 24696236
-
The inflammasome: a danger sensing complex triggering innate immunity.Curr Opin Immunol. 2007 Dec;19(6):615-22. doi: 10.1016/j.coi.2007.09.002. Epub 2007 Oct 30. Curr Opin Immunol. 2007. PMID: 17977705 Review.
-
Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation.Clin Exp Immunol. 2007 Feb;147(2):227-35. doi: 10.1111/j.1365-2249.2006.03261.x. Clin Exp Immunol. 2007. PMID: 17223962 Free PMC article. Review.
Cited by
-
Osthole decreases renal ischemia-reperfusion injury by suppressing JAK2/STAT3 signaling activation.Exp Ther Med. 2016 Oct;12(4):2009-2014. doi: 10.3892/etm.2016.3603. Epub 2016 Aug 22. Exp Ther Med. 2016. PMID: 27698686 Free PMC article.
-
Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis.J Control Release. 2023 Jan;353:621-633. doi: 10.1016/j.jconrel.2022.12.012. Epub 2022 Dec 14. J Control Release. 2023. PMID: 36503070 Free PMC article.
-
MicroRNA-21 in the pathogenesis of acute kidney injury.Protein Cell. 2013 Nov;4(11):813-9. doi: 10.1007/s13238-013-3085-y. Epub 2013 Nov 10. Protein Cell. 2013. PMID: 24214874 Free PMC article. Review.
-
Novel insights into NOD-like receptors in renal diseases.Acta Pharmacol Sin. 2022 Nov;43(11):2789-2806. doi: 10.1038/s41401-022-00886-7. Epub 2022 Apr 1. Acta Pharmacol Sin. 2022. PMID: 35365780 Free PMC article. Review.
-
The Effects of Free Heme on Functional and Molecular Changes During Ex Vivo Normothermic Machine Perfusion of Human Kidneys.Front Immunol. 2022 May 2;13:849742. doi: 10.3389/fimmu.2022.849742. eCollection 2022. Front Immunol. 2022. PMID: 35585981 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources